View Post

Are Oncologists Jumping the Gun with the 21-Gene Assay?

In In The News by Barbara Jacoby0 Comments

University of Colorado Cancer Center Study uncovers discrepant decision-making for use of 21-gene assay in women with cancer: Testing occurs in high-risk population, despite current evidence Non-concordance with NCCN Guidelines® recommendations Racial and socio-economic disparities found in testing use The 21-gene recurrence score (RS) assay, Oncotype DX™ (ODx), determines a score that estimates the likelihood of distant recurrence of disease …

View Post

Link between air pollution and breast cancer discovered

In In The News by Barbara Jacoby0 Comments

From: figo.org (International Federation of Gynecology and Obstetrics) Women living in areas that experience high levels of pollution could be at a higher risk of breast cancer, according to a new study. Research has suggested that increased exposure to soot particles could lead to denser breast tissue, which is one of the strongest risk factors linked to breast cancer. Those …

View Post

Do I Need To Change My Breast Implants Every 10 Years?

In In The News by Barbara Jacoby0 Comments

By: Jonathan Kaplan, MD / San Francisco, CA From: plasticsurgery.org The short answer is probably not. So if it’s not really necessary, why is it that every patient that researches breast augmentation has come across the magic number of 10? The need to replace breast implants (saline or silicone) every 10 years is based on factual data that has since …

View Post

SECOND CANCERS DEADLIER IN YOUNG PATIENTS

In In The News by Barbara Jacoby0 Comments

Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found. The study also found that survival after almost all types of cancer is much higher when the …

View Post

Vaccine may prevent progression of DCIS to breast cancer

In In The News by Barbara Jacoby0 Comments

From: healio.com Researchers at Mayo Clinic received a $3.7 million grant from the U.S. Department of Defense to test a vaccine designed to establish lifelong immunity against the development of breast cancer in women with ductal carcinoma in situ. No methods exist to detect which of the 35% of ductal carcinoma in situ (DCIS) cases will progress to cancer if …

View Post

The Human Vaccines Project, Vanderbilt And Illumina Join Forces To Decode The Human Immunome

In In The News by Barbara Jacoby0 Comments

From: PR Newswire The Human Vaccines Project and Vanderbilt University Medical Center today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system. Illumina will provide the genetic sequencing technologies and expertise required to process the massive amounts of data required to decode the human immunome. The Human Vaccines Project …

View Post

Cancer-detecting gum may soon be available

In In The News by Barbara Jacoby0 Comments

By: Ruth Ravve From: foxnews.com You won’t find it in your local candy store, but soon there may be a new chewing gum that could help save your life. It isn’t Juicy Fruit or Bazooka, but a gum being developed by an Alabama company called Volatile Analysis that’s designed to determine whether a person has cancer. The gum absorbs what …

View Post

Lehi biotech company developing cancer treatment drug

In In The News by Barbara Jacoby0 Comments

By: Jason Lee From: deseretnews.com David Bearss doesn’t remember his grandfather. The family patriarch was in his 40s when he was diagnosed with colon cancer in 1969 — the year Bearss was born. He died before Bearss was old enough to know him. “I have pictures of him holding me as a baby,” Bearss said. “But with cancer in those …

View Post

Slender women have a HIGHER risk of breast cancer, study warns

In In The News by Barbara Jacoby0 Comments

By: Mia De Graaf From: dailymail.co.uk Slender women have a higher risk of developing breast cancer, a new study warns. Scientists evaluated fat tissue from the breast and blood samples of 72 women with normal body-mass indices – less than 25. They found that 40 percent of them had ominous inflammation in their breast fat tissue. The reason, they believe, …

View Post

Trial Of Immune Drug In Breast Cancer Points To Need For Biomarkers

In In The News by Barbara Jacoby0 Comments

By: Elaine Schattner From: forbes.com At first glance, results with a powerful immune agent in breast cancer appear negative. In an early-phase clinical trial, only 10% of patients with metastatic disease responded to atezolizumab (Tecentriq). Yet for those few women who did respond, the benefit was dramatic. Among 112 women with evaluable, advanced disease, 11 have experienced durable responses lasting …